Your Impact
We're One Step Closer to a World
Without Cancer Thanks to You
We're One Step Closer to a World Without Cancer Thanks to You
YOUR IMPACT
Your generosity is making a life-changing difference in the lives of cancer patients and their families across Canada and beyond.
Every cancer diagnosis is devastating – but when it comes to research funding in Canada, some of the deadliest cancer types are underfunded relative to their cost to patients and society.
When you give to The Terry Fox Foundation, your donation supports high-impact research by the Terry Fox Research Institute that makes the greatest difference where it matters most – in the lives of patients.
To allocate its resources, the Terry Fox Research Institute has international experts evaluate the excellence and the potential for impact of all its research projects.
This approach allows donors to be confident that their investment is supporting the top 5% of Canadian researchers and their science.
YOUR IMPACT
Your generosity is making a life-changing difference in the lives of cancer patients and their families across Canada and beyond.
Every cancer diagnosis is devastating – but when it comes to research funding in Canada, some of the deadliest cancer types are underfunded relative to their cost to patients and society.
When you give to The Terry Fox Foundation, your donation supports high-impact research by the Terry Fox Research Institute that makes the greatest difference where it matters most – in the lives of patients.
To allocate its resources, the Terry Fox Research Institute has international experts evaluate the excellence and the potential for impact of all its research projects.
This approach allows donors to be confident that their investment is supporting the top 5% of Canadian researchers and their science.
WHY IT MATTERS
- Nearly 2 in 5 people in Canada will develop cancer during their lifetime.
- About 1 out of 4 Canadians are expected to die from cancer.
- New cancer cases expected to rise dramatically over the next decade.
- Today, data predicts the five-year net survival rate for all cancers to be 64%. In the 1940s, survival was only about 25%.
WHY IT MATTERS
- Nearly two in five people in Canada will develop cancer during their lifetime.
- About a third of all Canadian deaths are caused by some form of this disease.
- New cancer cases expected to rise dramatically over the next decade.
Recent Research Highlights
Recent Research Highlights
Improving the Accurary of Hereditary Cancer Screening
Li Fraumeni syndrome (LFS) is a rare, inherited condition causing cancer, and often multiple cancers, in nearly all those affected. Until recently, diagnosing this syndrome involved screening for a particular gene, which is only accurate roughly 70 per cent of the time. However, a Terry Fox Research Institute-funded team has identified new biomarkers that will improve the accuracy of existing screening protocols. They’ve also built a machine learning model to help predict cancer risk in patients with LFS. Together, their findings will contribute to the early detection and prevention of cancer, benefitting patients with this hereditary cancer syndrome.
Moving Findings from the Lab to the Clinic
Mapping the Immune System to Boost Immunotherapy in Ovarian Cancers
A team of Halifax-based researchers are exploring the power of natural killer (NK) cells to improve immunotherapies – a less toxic form of treatment involving the body’s own immune system – in ovarian cancer, particularly high-grade serous carcinoma where roughly half of all patients die. To help predict treatment outcomes, they’ve created a map that shows where immune cells are in relationship to tumours and how they interact with each other. Their findings will help determine which patients could benefit from immunotherapies that use NK cells, while setting the stage to find new ways to use these cells to make therapies more effective for more patients.
Using Artificial Intelligence to Predict who will Respond to Cancer Therapy
A Terry Fox Research Institute-funded team in Toronto is using artificial intelligence to analyze MRI, CT scan and ultrasound images of tumours, unlocking information that the human eye can’t see. In doing so, they’ve been able to find new ways to determine exactly how cancer patients will react to certain treatments – months before the treatment is ever administered.
Moving Findings from the Lab to the Clinic
Harnessing the Power of Light to Fight Cancer
Inspired by organisms found in nature, TFRI-funded researchers have created light-sensitive particles that could change how we treat cancer. These particles accumulate in tumours, and when activated by light, not only help surgeons locate tumours more accurately, but can also release drugs that kill cancer cells while sparing surrounding tissue.
We still have more to accomplish together. Canadians with cancer are depending on us – and on your continued support.
Thank you for bringing hope to those who need it most.
To view the Terry Fox Foundation Financial Statements in more detail, please click here.
For more information about the Terry Fox Research Institute, please visit their website: tfri.ca
We still have more to accomplish together. Canadians with cancer are depending on us – and on your continued support.
Thank you for bringing hope to those who need it most.
To view the Terry Fox Foundation Financial Statements in more detail, please click here.
For more information about the Terry Fox Research Institute, please visit their website: tfri.ca
